Articles with "two doses" as a keyword



A third booster dose may be necessary to mitigate neutralizing antibody fading after inoculation with two doses of an inactivated SARS-CoV-2 vaccine.

Sign Up to like & get
recommendations!
Published in 2021 at "Journal of medical virology"

DOI: 10.1002/jmv.27334

Abstract: Neutralizing antibodies in volunteers who received two doses of an inactivated SARS-CoV-2 vaccine deceased over several months. A three-dose procedure study suggested that the boost conferred by a third dose rescued the waning of neutralizing… read more here.

Keywords: cov vaccine; sars cov; doses inactivated; booster dose ... See more keywords

Evaluation of antibody response after two doses of the Sinovac vaccine and the potential need for booster doses in cancer patients

Sign Up to like & get
recommendations!
Published in 2022 at "Journal of Medical Virology"

DOI: 10.1002/jmv.27665

Abstract: Severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) is more severe in some specific patient groups, such as cancer patients with a mortality rate of 26.5%. The main way of protection is vaccination. In this study, we… read more here.

Keywords: sinovac vaccine; two doses; cancer patients; cancer ... See more keywords

Humoral immune response to two doses of COVID-19 mRNA-based vaccines in people living with HIV: A systematic review and meta-analysis.

Sign Up to like & get
recommendations!
Published in 2023 at "Reviews in medical virology"

DOI: 10.1002/rmv.2451

Abstract: People living with HIV (PLWH) are susceptible to severe COVID-19 infection and hence this fragile population has prioritised vaccination. This systematic review and meta-analysis aimed to assess the humoral immune response after receiving two doses… read more here.

Keywords: cells mm3; two doses; vaccination; humoral immune ... See more keywords

Effect of simultaneous vaccination with H1N1 and GAD-alum on GAD65-induced immune response

Sign Up to like & get
recommendations!
Published in 2017 at "Diabetologia"

DOI: 10.1007/s00125-017-4263-x

Abstract: Aims/hypothesisA European Phase III trial of GAD formulated with aluminium hydroxide (GAD-alum) failed to reach its primary endpoint (preservation of stimulated C-peptide secretion from baseline to 15 months in type 1 diabetes patients), but subgroup analysis… read more here.

Keywords: gad alum; alum; vaccination; gad65 induced ... See more keywords

Two doses of fosaprepitant included prophylactic treatment for the three-day cisplatin-based chemotherapy induced nausea and vomiting

Sign Up to like & get
recommendations!
Published in 2024 at "Journal of Cancer Research and Clinical Oncology"

DOI: 10.1007/s00432-024-05766-7

Abstract: Neurokinin 1 receptor antagonists included prophylactic treatment was recommended for patients who receive one-day cisplatin chemotherapy. It is unclear whether the prolonged administration of fosaprepitant is effective for three-day cisplatin-based chemotherapy induced nausea and vomiting… read more here.

Keywords: day cisplatin; group; chemotherapy; three day ... See more keywords

Two flares of Still’s disease after two doses of the ChAdOx1 vaccine

Sign Up to like & get
recommendations!
Published in 2022 at "Clinical Rheumatology"

DOI: 10.1007/s10067-022-06124-z

Abstract: We report the case of an 18-year-old male with Still’s disease for the last 3 years, in remission, who developed two flares of his disease after receiving two doses of the ChAdOX1 nCoV-19 vaccine. While… read more here.

Keywords: two doses; flares still; doses chadox1; vaccine ... See more keywords

Early antibody response in health-care professionals after two doses of SARS-CoV-2 mRNA vaccine (BNT162b2)

Sign Up to like & get
recommendations!
Published in 2021 at "Clinical Microbiology and Infection"

DOI: 10.1016/j.cmi.2021.05.004

Abstract: Objectives Data on the immune response after two doses of BNT162b2 are so far limited. Previously infected individuals were excluded from pivotal clinical trials and the optimal dose regimen in this population has not been… read more here.

Keywords: response; previously infected; antibody; antibody response ... See more keywords
Photo from wikipedia

Decline of antibody titres three months after two doses of BNT162b2 in non-immunocompromised adults

Sign Up to like & get
recommendations!
Published in 2021 at "Clinical Microbiology and Infection"

DOI: 10.1016/j.cmi.2021.08.023

Abstract: Objective To assess the antibody response in non-immunocompromised adults after two doses of BNT162b2. Methods Prospective, single-centre observational study in non-immunocompromised adults > 18 years of age who received two doses of BNT162b2. The study contemplates… read more here.

Keywords: doses bnt162b2; three months; non immunocompromised; immunocompromised adults ... See more keywords

Antibody response to COVID-19 vaccine: A point of view that can help to optimize dose distribution

Sign Up to like & get
recommendations!
Published in 2021 at "International Immunopharmacology"

DOI: 10.1016/j.intimp.2021.108406

Abstract: The global strategy to control coronavirus disease is based on the availability of COVID-19 vaccines. More information about response to a single dose vaccine could help to better understand and optimize the management of the… read more here.

Keywords: response; two doses; response covid; antibody response ... See more keywords

Pharmacokinetic Evaluation of Red Raspberry (Poly)phenols from Two Doses and Association with Metabolic Indices in Adults with Prediabetes and Insulin Resistance.

Sign Up to like & get
recommendations!
Published in 2021 at "Journal of agricultural and food chemistry"

DOI: 10.1021/acs.jafc.1c02404

Abstract: This study aimed to investigate pharmacokinetic variables of two doses of red raspberry (RR) (poly)phenols and their association with metabolic indices in adults with prediabetes and insulin resistance (preDM-IR) compared to metabolically healthy adults (reference).… read more here.

Keywords: raspberry poly; metabolic indices; red raspberry; poly phenols ... See more keywords

Single versus two doses of palonosetron for prevention of chemotherapy-induced nausea and vomiting in children: a double-blind placebo controlled randomized study.

Sign Up to like & get
recommendations!
Published in 2025 at "Journal of chemotherapy"

DOI: 10.1080/1120009x.2025.2488598

Abstract: This single-centre, double-blinded, placebo-controlled randomized study aimed to assess the efficacy of single versus two doses of palonosetron in the prevention of chemotherapy-induced nausea and vomiting (CINV). Children receiving multiple-day (scheduled for ≥3 days) moderately or… read more here.

Keywords: chemotherapy; controlled randomized; placebo controlled; randomized study ... See more keywords